Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): A case series

Archives of Women's Mental Health

Volumn 10, Issue 3, 2007, Pages 125-127

  Ravindran, L N ^a   Woods, S A ^b   Steiner, M ^c   Ravindran, A V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Citalopram; Premenstrual dysphoric disorder; Psychopharmacology; Symptom onset dosing

Indexed keywords

CITALOPRAM;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; NAUSEA; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; RATING SCALE; RESTLESSNESS; SIDE EFFECT; SYMPTOM; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUTEAL PHASE; MIDDLE AGED; PATIENT SATISFACTION; PREMENSTRUAL SYNDROME; PSYCHIATRIC STATUS RATING SCALES; RESEARCH DESIGN; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 34249803827     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-007-0181-0     Document Type: Article

References (15)

1. EW Freeman 2004 Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder CNS Drugs 18 453 468
2. EW Freeman SJ Sondheimer MD Sammel T Ferdousi H Lin 2005 A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder J Clin Psych 66 769 773
3. Guy W (1976) ECDEU assessment of manual for psychopharmacology. NIMH Public Department of Health, Education and Human Welfare Publication NO. (Adm.) 76-338 (Revised). Rockvill MA, pp 217-222.
4. SG Kornstein TB Pearlstein R Fayyad GM Farfel JA Gillespie 2006 Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies J Clin Psychiatry 67 1624 1632
5. M Landen H Nissbrandt C Allgulander K Sorvik C Ysander E Eriksson 2007 Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder Neuropsychopharmacology 32 153 161
6. SA Montgomery M Asberg 1979 A new depression scale designed to be sensitive to change Br J Psychiatry 134 382 389
7. TB Pearlstein U Halbreich ED Batzar CS Brown J Endicott E Frank EW Freeman WM Harrison RF Haskett AL Stout KA Yonkers 2000 Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo J Clin Psychiatry 61 101 109
8. T Pearlstein KA Yonkers R Fayyad JA Gillespie 2005 Pretreatment pattern of symptom expression in premenstrual dysphoric disorder J Affect Disord 85 275 282
9. A Rapkin 2003 A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder Psychoneuroendocrinology 28 Suppl 3 39 53
10. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller T Hergueta R Baker GC Dunbar 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl 20 22 33
11. M Steiner T Pearlstein 2000 Premenstrual dysphoria and the serotonin system: pathophysiology and treatment J Clin Psychiatry 61 Suppl 12 17 21
12. M Steiner RF Haskett BJ Carroll 1980 Premenstrual tension syndrome: The development of research diagnostic criteria and new rating scales Acta Psychiatr Scand 62 177 190
13. M Steiner E Brown P Trzepacz J Dillon C Berger D Carter R Reid D Stewart 2003 Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder Arch Womens Ment Health 6 71 77
14. M Steiner AL Hirschberg R Bergeron F Holland MD Gee E Van Erp 2005 Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder Am J Obstet Gynecol 193 352 360
15. Wyatt KM, Dimmock PW, O'Brien PMS (2002) Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD001396. DOI:10.1002/14651858.CD001396.